Exploring the hype around anti-malarial hydroxychloroquine

Allie Nawrat 14 April 2020 (Last Updated April 14th, 2020 15:08)

Hydroxychloroquine has attracted significant news coverage over the past two weeks as a potential treatment for Covid-19.

Approved to treat malaria and lupus, hydroxychloroquine has been heralded by US President Donald Trump as a very promising drug to fight Covid-19 or what he calls the ‘invisible enemy’ during his press briefings over the 4 and 5 April.

Trump’s remarks have baffled his scientific and medical advisors, most notably Dr Anthony Fauci, director of National Institute of Allergy and Infectious Diseases, who has repeatedly emphasised that the evidence supporting hydroxychloroquine is “anecdotal” at best.

Despite what President Trump may claim, it is crucial that this drug goes through clinical trials before it can be widely prescribed safely to Covid-19 patients.

Read the full article here.